×
For best experience we recommend to activate Javascript in your browser.
CECR1 antibody (AA 30-511)
This Rabbit Polyclonal antibody specifically detects CECR1 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for CECR1 antibody (AA 30-511) (ABIN7613662)
Target
See all CECR1 Antibodies
CECR1
(Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1))
Reactivity
Human
Host
All hosts for CECR1 antibodies
Rabbit
Clonality
All clonalities for CECR1 antibodies
Polyclonal
Conjugate
All conjugates for CECR1 antibodies
This CECR1 antibody is un-conjugated
Application
All applications for CECR1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-CECR1 Antibody
(hide)
Binding Specificity
All epitopes for CECR1 antibodies
AA 30-511
Purpose
Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Polyclonal Antibody
Sequence
Ile30~Lys511
Characteristics
The Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for CECR1
(hide)
Target
CECR1
(Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1))
Alternative Name
CECR1
Gene ID
51816
UniProt
Q9NZK5
Pathways
Ribonucleoside Biosynthetic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat